Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
This is the 2006 version of HCPCS G9078 - please refer to the 2016 HCPCS code set for the latest version.
Status changed on Sunday, January 01, 2006 to: Add procedure or modifier code
